Alison R. Wakoff, MD | Authors

OMNICARE PHARMACY

105 MILLIGAN PL

Articles

Commentary (Wakoff/Porter): The Biology and Treatment of Chronic Myelogenous Leukemia

January 01, 2001

Over the past 2 decades, our understanding of the pathobiological events underlying chronic myelogenous leukemia (CML) has grown. At the same time, effective transplant and nontransplant treatment approaches to